Follow this preprint

Real-world evidence with a retrospective cohort of 15,968 Andalusian COVID-19 hospitalized patients suggests 21 new effective treatments and one drug that increases death risk

Carlos Loucera, Rosario Carmona, Marina Esteban-Medina, Gerrit Bostelmann, Dolores Muñoyerro-Muñiz, Román Villegas, María Peña-Chilet, Joaquin Dopazo
doi: https://doi.org/10.1101/2022.08.14.22278751
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2022.08.14.22278751
History 
  • August 16, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Carlos Loucera1,2,
  2. Rosario Carmona1,2,3,
  3. Marina Esteban-Medina1,2,
  4. Gerrit Bostelmann1,
  5. Dolores Muñoyerro-Muñiz4,
  6. Román Villegas4,
  7. María Peña-Chilet1,2,3 and
  8. Joaquin Dopazo1,2,3,5,*
  1. 1Computational Medicine Platform, Andalusian Public Foundation Progress and Health-FPS, Sevilla, 41013, Spain
  2. 2Institute of Biomedicine of Seville, IBiS, University Hospital Virgen del Rocío/CSIC/University of Seville, Spain
  3. 3Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). FPS. Hospital Virgen del Rocio. 41013. Sevilla. Spain
  4. 4Subdirección Técnica Asesora de Gestión de la Información. Servicio Andaluz de Salud. 41071, Sevilla, Spain
  5. 5FPS/ELIXIR-ES, Fundación Progreso y Salud (FPS). CDCA, Hospital Virgen del Rocio. 41013. Sevilla. Spain
  1. ↵* Corresponding author; email: joaquin.dopazo{at}juntadeandalucia.es
Back to top
Posted August 16, 2022.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Real-world evidence with a retrospective cohort of 15,968 Andalusian COVID-19 hospitalized patients suggests 21 new effective treatments and one drug that increases death risk
Carlos Loucera, Rosario Carmona, Marina Esteban-Medina, Gerrit Bostelmann, Dolores Muñoyerro-Muñiz, Román Villegas, María Peña-Chilet, Joaquin Dopazo
medRxiv 2022.08.14.22278751; doi: https://doi.org/10.1101/2022.08.14.22278751
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.